| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |